文献速递乳腺乳腺X线

对比增强数字乳腺X线摄影用于浸润性小叶癌术前局部区域分期

Preoperative loco-regional staging of invasive lobular carcinoma with contrast-enhanced digital mammography (CEDM).
PubMed 文献 · Radiol Med · 2019-11-26

回顾性分析31例浸润性小叶癌患者,评估对比增强数字乳腺X线摄影(CEDM)术前局部区域分期的效能。CEDM对索引病灶检出敏感度100%,对附加病灶检出敏感度84.2%、特异度66.7%,病变范围评估正确率77.4%;非肿块强化(NME)为降低诊断准确性的主要因素。

要点

  • CEDM对浸润性小叶癌索引病灶检出敏感度达100%,对附加病灶检出敏感度84.2%。
  • 非肿块强化(NME)使附加病灶检出敏感度降至25%,病灶范围评估准确率降至40%。
  • CEDM在38.7%(12/31)病例中识别出传统影像未显示的病灶,其中6例为多中心病变并改变手术规划。

核心结论

  • CEDM是浸润性小叶癌术前局部区域分期和病变范围评估中有前景的新影像技术,尤其在肿块强化病灶中表现更佳。

研究设计与样本

  • 回顾性研究,纳入2016年9月至2018年11月在佛罗伦萨Careggi大学医院乳腺诊断科和米兰国家癌症研究所行CEDM的1500例患者中31例经组织学确诊为浸润性小叶癌的女性(平均年龄57.1岁,范围41-78岁)。
  • 以 definitive 组织学诊断为参考标准,评估CEDM对索引病灶检出、附加病灶识别及病变范围测量的效能。

关键影像表现/征象

  • CEDM对索引病灶检出敏感度100%,对附加病灶检出敏感度84.2%、特异度66.7%。
  • 非肿块强化(NME)使附加病灶检出敏感度降至25%,而肿块样强化或肿块伴NME为100%。
  • 病变范围评估正确率77.4%;NME使评估准确率降至40%,肿块为85%,肿块伴NME为80%。
  • CEDM在12/31(38.7%)中正确识别出乳腺X线摄影+超声+断层合成未显示的病灶,其中6/12为多中心病变并据此调整手术规划。
  • CEDM分析肿块最大直径准确,但对肿块伴NME和纯NME可靠性明显降低。

诊断标准与关键数值

  • 索引病灶检出敏感度100%(CEDM vs 组织学参考标准)。
  • 附加病灶检出敏感度84.2%、特异度66.7%(CEDM vs 组织学参考标准)。
  • 病变范围评估正确率77.4%;NME 40% vs 肿块85% vs 肿块伴NME 80%。

临床应用与阅片要点

  • CEDM可用于浸润性小叶癌术前评估病变范围,尤其肿块强化病灶可靠性较高。
  • 出现非肿块强化(NME)时,CEDM对附加病灶和范围评估的准确性下降,需结合其他影像谨慎判读。
  • CEDM可发现传统影像(乳腺X线摄影+超声+断层合成)未显示的附加病灶,其中多中心病变可能影响手术规划。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

The aim of our study was to assess the performance of contrast-enhanced digital mammography (CEDM) in the preoperative loco-regional staging of invasive lobular carcinoma (ILC) patients, about the valuation of the extension of disease and in measurement of lesions. Then, we selected retrospectively, among the 1500 patients underwent to CEDM at the Breast Diagnostics Department of the Careggi University Hospital of Florence and the National Cancer Institute of Milan from September 2016 to November 2018, 31 women (mean age 57.1 aa; range 41-78 aa) with a definitive histological diagnosis of ILC. CEDM has proved to be a promising imaging technique, being characterized by a sensitivity of 100% in the detection of the index lesion, and of 84.2% in identifying any adjunctive lesions: It was the presence of a non-mass enhancement (NME) to lower the sensitivity of the technique (25% vs. 100% for mass-like enhancements or a mass closely associated with a NME). Specificity in the characterization of additional lesions was 66.7%, and the diagnosis of the extension of disease was correct in 77.4% of cases: NME also led to a decrease in diagnostic accuracy in the evaluation of disease extension up to 40% versus 85% for masses and 80% for masses associated with NME (M/NME). Moreover, in 12/31 (38.7%), CEDM allowed to correctly identify lesions not shown by mammography + ultrasonography + tomosynthesis: In the half of these (6/12), there was a multicentricity, thus allowing an adequate surgical planning change. CEDM was also very accurate in analyzing the maximum diameter of the masses, while it was much less reliable in the case of the M/NME and pure NME. In conclusion, CEDM is a new promising imaging technique in the loco-regional preoperative staging and in the evaluation of disease extension for ILC, especially in case of mass enhancement lesions.

来源:Radiol Med,查看原文。版权归原作者所有。

引用

  1. Amato F, Bicchierai G, Cirone D, et al. Preoperative loco-regional staging of invasive lobular carcinoma with contrast-enhanced digital mammography (CEDM). Radiol Med. 2019. PMID: 31773458. doi:10.1007/s11547-019-01116-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。